About this episode

This episode discusses the impact of U.S. anti-DEI policies on equity in medicine and the broader implications for scientific discovery and medical education.

The ripple effects of U.S. anti-DEI policies extend far beyond individual labs: scientific discovery is slowing, early‑career investigators are reconsidering their futures, and the pipeline of medical school applicants is shifting in real time. A full transcript of this episode is available at https://www.nejm.org/doi/full/10.1056/NEJMp2601982.

People in this episode

Host: NEJM Group

Topics covered

• equity in medicine
• anti-DEI policies
• scientific discovery
• medical education
• early-career investigators

Keywords

• equity
• medicine
• anti-DEI
• scientific discovery
• medical school applicants

Mentioned in this episode

Organizations: U.S.

More episodes of Intention to Treat

• Is Change Possible? · June 17, 2026 · 24 min
• The Myth of Race and Genetics · June 10, 2026 · 27 min
• BiDil — The Story of the Black Pill · June 3, 2026 · 25 min
• When Race Matters · May 27, 2026 · 27 min
• Money and Misdiagnosis · May 20, 2026 · 24 min
• How Did Race Get Into Lung Testing? · May 13, 2026 · 31 min

Explore listener stats, chart rankings, contacts and more on the Intention to Treat podcast page.